3940 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 28
18:36 UTC
|
XOM
ExxonMobil
|
↓ Downgrade | Jean Ann Salisbury ★★★★☆ #872 | Buy→ Neutral | $154.00→ $158.00+2.6% |
|
Jul 28
17:36 UTC
|
SYRE
Spyre Therapeutics
|
↓ Downgrade | Andy Chen ★★★★☆ #648 | Outperform→ Peer Perform | |
|
Jul 28
17:36 UTC
|
PYPL
PayPal
|
↓ Downgrade | Timothy Chiodo ★★★☆☆ #1134 | Neutral→ Hold | |
|
Jul 28
17:36 UTC
|
INSP
Inspire Medical Systems
|
↓ Downgrade | Patrick Wood ★★★★☆ #527 | Neutral→ Sell | $67.00→ $39.00-41.8% |
|
Jul 28
16:36 UTC
|
KOF
Coca Cola Femsa
|
↓ Downgrade | Carlos Laboy ★★☆☆☆ #2722 | Buy→ Hold | $116.00 |
|
Jul 28
16:36 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★☆☆☆ #2646 | Buy→ Hold | $504.00→ $304.00-39.7% |
|
Jul 28
15:35 UTC
|
KOF
Coca Cola Femsa
|
↓ Downgrade | firm only | Buy→ Hold | $116.00 |
|
Jul 28
15:35 UTC
|
ISRG
Intuitive Surgical
|
↓ Downgrade | Mathew Blackman ★★★☆☆ #1803 | Buy→ Hold | |
|
Jul 28
13:35 UTC
|
XOM
ExxonMobil
|
↓ Downgrade | Jean Ann Salisbury ★★★★☆ #872 | Buy→ Neutral | $158.00 |
|
Jul 28
13:35 UTC
|
SYRE
Spyre Therapeutics
|
↓ Downgrade | firm only | Outperform→ Peer Perform | |
|
Jul 28
13:35 UTC
|
PODD
Insulet
|
↓ Downgrade | firm only | Buy→ Neutral | $174.00 |
|
Jul 28
13:35 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★☆☆☆ #2646 | Buy→ Hold | $304.00 |
|
Jul 28
13:35 UTC
|
INSP
Inspire Medical Systems
|
↓ Downgrade | firm only | Neutral→ Sell | |
|
Jul 28
13:35 UTC
|
GKOS
Glaukos
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jul 28
13:35 UTC
|
FMS
Fresenius Medical Care AG & Co. KGaA
|
↓ Downgrade | firm only | Neutral→ Underperform | $19.90 |
|
Jul 28
13:35 UTC
|
EBC
Eastern Bankshares
|
↓ Downgrade | Matt Breese not yet tracked | Overweight→ Equal Weight | $24.00 |
|
Jul 28
12:43 UTC
|
VC
Visteon
|
↓ Downgrade | Emmanuel Rosner ★★☆☆☆ #2781 | Outperform→ Peer Perform | |
|
Jul 28
12:43 UTC
|
SIGI
Selective Insurance Group
|
↓ Downgrade | Michael Zaremski ★★★★☆ #575 | Outperform→ Market Perform | $97.00 |
|
Jul 28
12:43 UTC
|
PRCT
PROCEPT BioRobotics
|
↓ Downgrade | firm only | Buy→ Neutral | $20.00 |
|
Jul 28
12:43 UTC
|
PODD
Insulet
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Jul 28
12:43 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | Etzer Darout ★★☆☆☆ #2407 | Overweight→ Equal Weight | $74.00→ $77.00+4.1% |
|
Jul 28
12:43 UTC
|
CLX
Clorox
|
↓ Downgrade | Kaumil Gajrawala ★★★★☆ #692 | Buy→ Hold | $125.00→ $98.00-21.6% |
|
Jul 28
12:43 UTC
|
BMRC
Bank of Marin Bancorp
|
↓ Downgrade | firm only | Buy→ Neutral | $33.00 |
|
Jul 28
11:43 UTC
|
SIGI
Selective Insurance Group
|
↓ Downgrade | Michael Zaremski ★★★★☆ #575 | Outperform→ Market Perform | |
|
Jul 28
11:43 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★☆☆☆ #2646 | Buy→ Hold | |
|
Jul 28
11:43 UTC
|
FMS
Fresenius Medical Care AG & Co. KGaA
|
↓ Downgrade | firm only | Underperform | $19.90 |
|
Jul 28
11:43 UTC
|
CLX
Clorox
|
↓ Downgrade | Kaumil Gajrawala ★★★★☆ #692 | Positive→ Hold | |
|
Jul 28
10:43 UTC
|
INTU
Intuit
|
↓ Downgrade | Jared Levine ★★☆☆☆ #2646 | Buy→ Negative | |
|
Jul 28
10:43 UTC
|
FMS
Fresenius Medical Care AG & Co. KGaA
|
↓ Downgrade | firm only | Underperform | |
|
Jul 28
10:43 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | Etzer Darout ★★☆☆☆ #2407 | Overweight→ Positive | $77.00 |
|
Jul 28
02:41 UTC
|
LAUR
Laureate Education
|
↓ Downgrade | firm only | Equal Weight→ Underweight | $34.50 |
|
Jul 28
01:41 UTC
|
LAUR
Laureate Education
|
↓ Downgrade | firm only | Equal Weight→ Underweight | |
|
Jul 28
00:41 UTC
|
XROLF
Xero
|
↓ Downgrade | firm only | Outperform→ Sector Perform | |
|
Jul 28
00:41 UTC
|
VALE
Vale
|
↓ Downgrade | Marcio Farid ★★★☆☆ #2102 | Buy→ Neutral | $18.00→ $16.00-11.1% |
|
Jul 28
00:41 UTC
|
UTZ
Utz Brands
|
↓ Downgrade | Rob Dickerson not yet tracked | Buy→ Neutral | |
|
Jul 28
00:41 UTC
|
STLA
Stellantis
|
↓ Downgrade | firm only | Overweight→ Underweight | $4.00 |
|
Jul 28
00:41 UTC
|
STC
Stewart Information Services
|
↓ Downgrade | Bose George ★★★☆☆ #2166 | Outperform→ Market Perform | $77.00→ $71.00-7.8% |
|
Jul 28
00:41 UTC
|
FSBW
FS Bancorp
|
↓ Downgrade | firm only | Buy→ Neutral | $45.00 |
|
Jul 28
00:41 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | firm only | Hold | |
|
Jul 28
00:41 UTC
|
DBM
Doman Building Materials Group
|
↓ Downgrade | firm only | Strong-Buy→ Outperform | C$12.00 |
|
Jul 28
00:41 UTC
|
CORZ
Core Scientific
|
↓ Downgrade | firm only | Outperform→ Market Perform | $25.00 |
|
Jul 28
00:41 UTC
|
CHKP
Check Point Software Technologies
|
↓ Downgrade | Brian Essex ★★★☆☆ #2041 | Overweight→ Neutral | $135.00 |
|
Jul 28
00:41 UTC
|
CAT
Caterpillar
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Jul 28
00:41 UTC
|
CAPR
Capricor Therapeutics
|
↓ Downgrade | Boobalan Pachaiyappan ★★☆☆☆ #2811 | Buy→ Neutral | $7.00 |
|
Jul 27
22:41 UTC
|
XROLF
Xero
|
↓ Downgrade | firm only | Outperform→ Sector Perform | |
|
Jul 27
20:40 UTC
|
CAPR
Capricor Therapeutics
|
↓ Downgrade | Boobalan Pachaiyappan ★★☆☆☆ #2811 | Buy→ Neutral | $7.00 |
|
Jul 27
19:40 UTC
|
VALE
Vale
|
↓ Downgrade | Marcio Farid ★★★☆☆ #2102 | Buy→ Neutral | $18.00→ $16.00-11.1% |
|
Jul 27
18:40 UTC
|
DBM
Doman Building Materials Group
|
↓ Downgrade | firm only | Strong-Buy→ Outperform | C$12.00 |
|
Jul 27
16:40 UTC
|
STC
Stewart Information Services
|
↓ Downgrade | Bose George ★★★☆☆ #2166 | Outperform→ Market Perform | $77.00→ $71.00-7.8% |
|
Jul 27
14:40 UTC
|
FBRX
Forte Biosciences
|
↓ Downgrade | firm only | Hold |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.